National Health (Price and Special Patient Contribution) Amendment Determination 2017 (No. 2) (PB 16 of 2017) (Cth)

PB 16 of 2017

National Health (Price and Special Patient Contribution) Amendment Determination 2017 (No. 2)

National Health Act 1953

I, LOUISE CLARKE, First Assistant Secretary (Acting), Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.

Dated 30^th March 2017

LOUISE CLARKE

First Assistant Secretary (Acting)

Pharmaceutical Benefits Division

Department of Health

1          Name of Instrument

(1)        This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2017 (No. 2).

(2)        This Instrument may also be cited as PB 16 of 2017.

2          Commencement

This Instrument commences on 1 April 2017.

3          Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).

Schedule 1     Amendments

[1]Schedule 1, after entry for Candesartan with Hydrochlorothiazide in the form Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 25 mg

insert:

Capecitabine Tablet 500 mg Oral Xeloda 120 129.51 135.99

[2] Schedule 1, entry for Enalapril in the form Tablet containing enalapril maleate 10 mg

omit from the column headed “Claimed Price”:          7.53        substitute:             8.79

[3] Schedule 1, entry for Enalapril in the form Tablet containing enalapril maleate 20 mg

omit from the column headed “Claimed Price”:          8.42        substitute:             9.67

[4]Schedule 1, entry for Erythromycin

omit:

Tablet 400 mg (as ethyl succinate) Oral E.E.S. 400 Filmtab 25 4.56 6.72

[5] Schedule 1, omit entry for Glibenclamide

[6] Schedule 1, entry for Gliclazide

omit from the column headed “Claimed Price”:          8.55        substitute:             11.34

[7]Schedule 1, after entry for Perindopril with indapamide in the form Tablet containing perindopril arginine 5 mg with indapamide hemihydrate 1.25 mg

insert in the columns in the order indicated:

Tablet containing perindopril erbumine 4 mg with indapamide hemihydrate 1.25 mg Oral Perindo Combi 4/1.25 30 4.10 6.84

[8]Schedule 1, entry for Prednisolone in the form Tablet 1 mg

(a)   omit from the column headed “Determined Price”:             1.54        substitute:             2.38

(b)   omit from the column headed “Claimed Price”:                  2.20        substitute:             3.31

[9]Schedule 1, entry for Prednisone

(a)   omit from the column headed “Determined Price”:             1.97        substitute:             2.33

(b)   omit from the column headed “Claimed Price”:                  2.71        substitute:             3.26

1. Schedule 1, after entry for Salbutamol in the form Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30 [Brand: Ventolin Nebules]

insert in the columns in the order indicated:

Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 20 Inhalation Ventolin Nebules 1 2.61 2.92